Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.05 EUR
−9.41 M EUR
66.96 M EUR
114.10 M
About Inuvo, Inc.
Sector
Industry
CEO
Richard K. Howe
Website
Headquarters
Little Rock
Founded
1987
FIGI
BBG000MSKN00
Inuvo, Inc. engages in the business of developing and selling information technology solutions for marketing and advertising. Its products and services include IntentKey and Bonfire. The company was founded in October 1987 and is headquartered in Little Rock, AR.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CD5N is 0.38 EUR — it has decreased by −0.75% in the past 24 hours. Watch INUVO INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange INUVO INC stocks are traded under the ticker CD5N.
CD5N stock has fallen by −1.61% compared to the previous week, the month change is a −5.60% fall, over the last year INUVO INC has showed a −16.41% decrease.
We've gathered analysts' opinions on INUVO INC future price: according to them, CD5N price has a max estimate of 0.96 EUR and a min estimate of 0.96 EUR. Watch CD5N chart and read a more detailed INUVO INC stock forecast: see what analysts think of INUVO INC and suggest that you do with its stocks.
CD5N reached its all-time high on Mar 3, 2021 with the price of 1.12 EUR, and its all-time low was 0.12 EUR and was reached on Nov 1, 2023. View more price dynamics on CD5N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CD5N stock is 5.74% volatile and has beta coefficient of 0.55. Track INUVO INC stock price on the chart and check out the list of the most volatile stocks — is INUVO INC there?
Today INUVO INC has the market capitalization of 58.13 M, it has increased by 0.72% over the last week.
Yes, you can track INUVO INC financials in yearly and quarterly reports right on TradingView.
INUVO INC is going to release the next earnings report on May 8, 2025. Keep track of upcoming events with our Earnings Calendar.
INUVO INC revenue for the last quarter amounts to 25.30 M EUR, despite the estimated figure of 24.34 M EUR. In the next quarter, revenue is expected to reach 18.40 M EUR.
CD5N net income for the last quarter is −1.84 M EUR, while the quarter before that showed −1.63 M EUR of net income which accounts for −12.56% change. Track more INUVO INC financial stats to get the full picture.
No, CD5N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 28, 2025, the company has 91.00 employees. See our rating of the largest employees — is INUVO INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INUVO INC EBITDA is −4.90 M EUR, and current EBITDA margin is −10.34%. See more stats in INUVO INC financial statements.
Like other stocks, CD5N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INUVO INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INUVO INC technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INUVO INC stock shows the buy signal. See more of INUVO INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.